| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.857 | 182.519 | 268.979 | 373.944 | 785.624 | 710.570 | 815.620 | 827.228 |
| Total Income - EUR | - | - | 4.857 | 183.363 | 273.327 | 386.848 | 796.202 | 717.298 | 823.813 | 851.680 |
| Total Expenses - EUR | - | - | 15.056 | 178.739 | 255.730 | 356.904 | 696.489 | 640.960 | 708.523 | 788.165 |
| Gross Profit/Loss - EUR | - | - | -10.199 | 4.623 | 17.597 | 29.944 | 99.713 | 76.338 | 115.290 | 63.516 |
| Net Profit/Loss - EUR | - | - | -10.248 | 2.708 | 15.420 | 27.253 | 93.679 | 70.471 | 106.245 | 50.025 |
| Employees | - | - | 3 | 6 | 7 | 9 | 12 | 12 | 10 | 10 |
Check the financial reports for the company - Goldansia Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 51.344 | 53.281 | 63.398 | 82.335 | 81.046 | 129.813 | 288.033 | 323.221 |
| Current Assets | - | - | 8.947 | 1.296 | 7.854 | 38.497 | 57.669 | 7.963 | 29.946 | 28.700 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 1.155 | 0 | 971 | 2.389 | 1.003 | 1.571 | 3.706 |
| Cash | - | - | 8.947 | 141 | 7.854 | 37.526 | 55.280 | 6.960 | 28.375 | 24.994 |
| Shareholders Funds | - | - | -10.204 | -7.309 | 8.253 | 27.308 | 93.738 | 70.532 | 106.312 | 50.100 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 70.495 | 61.886 | 63.000 | 93.525 | 44.978 | 67.243 | 211.667 | 301.821 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Goldansia Med Srl